HRS5580

· Fujian Shengdi Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS5580, covering 2025-01-20 to 2025-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults [Phase 2]